A review of the use of magnetic resonance imaging in Parkinson’s disease

Therapeutic Advances in Neurological Disorders

Volumn 7, Issue 4, 2014, Pages 206-220

  Pyatigorskaya, Nadya ^a   Gallea, Cécile ^b   Garcia Lorenzo, Daniel ^b   Vidailhet, Marie ^a   Lehericy, Stéphane ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

Author keywords

diffusion tensor imaging; magnetization transfer; relaxometry; resting state fMRI

Indexed keywords

4 AMINOBUTYRIC ACID; CHOLINE DERIVATIVE; CREATINE; CREATINE PHOSPHATE; GLUTAMIC ACID; GLUTATHIONE; INOSITOL; IRON; LACTIC ACID; N ACETYLASPARTIC ACID; NEUROTRANSMITTER;

APPARENT DIFFUSION COEFFICIENT; BASAL GANGLION; BOLD SIGNAL; BRAIN CORTEX ATROPHY; BRAIN SIZE; BRAIN STEM; CEREBELLUM; CONNECTOME; CORPUS STRIATUM; CORTICAL THICKNESS (BRAIN); DEFAULT MODE NETWORK; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; EXECUTIVE FUNCTION; FRACTIONAL ANISOTROPY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLOBUS PALLIDUS; GRAY MATTER; HUMAN; LOCUS CERULEUS; MAGNETIZATION TRANSFER RATIO; MEAN DIFFUSIVITY; MILD COGNITIVE IMPAIRMENT; MOTOR PERFORMANCE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PHYSICAL PARAMETERS; PREMOTOR CORTEX; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTON NUCLEAR MAGNETIC RESONANCE; RED NUCLEUS; REVIEW; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; SUPPLEMENTARY MOTOR AREA; SUSCEPTIBILITY WEIGHTED IMAGING; TEGMENTUM; TEMPORAL LOBE; TRACTOGRAPHY; TREMOR; VOXEL BASED MORPHOMETRY; WHITE MATTER;

EID: 84904017675     PISSN: 17562856     EISSN: 17562864     Source Type: Journal    
DOI: 10.1177/1756285613511507     Document Type: Review

References (140)

1. Alexander D. (2008) A general framework for experiment design in diffusion MRI and its application in measuring direct tissue-microstructure features. Magn Reson Med 60: 439–448.
2. Apostolova L. Thompson P. (2007) Brain mapping as a tool to study neurodegeneration. Neurotherapeutics 4: 387–400.
3. Arabia G. Morelli M. Paglionico S. Novellino F. Salsone M. Giofre L. et al. (2010) An magnetic resonance imaging T2*-weighted sequence at short echo time to detect putaminal hypointensity in Parkinsonisms. Mov Disord 25: 2728–2734.
4. Ashburner J. Friston K. (2000) Voxel-based morphometry - the methods. Neuroimage 11: 805–821.
5. Assaf Y. Blumenfeld-Katzir T. Yovel Y. Basser P. (2008) AxCaliber: a method for measuring axon diameter distribution from diffusion MRI. Magn Reson Med 59: 1347–1354.
6. Barbiroli B. Martinelli P. Patuelli A. Lodi R. Iotti S. Cortelli P. et al. (1999) Phosphorus magnetic resonance spectroscopy in multiple system atrophy and Parkinson's disease. Mov Disord 14: 430–435.
7. Baudrexel S. Nurnberger L. Rub U. Seifried C. Klein J. Deller T. et al. (2010) Quantitative mapping of T 1 and T2* discloses nigral and brainstem pathology in early Parkinson's disease. Neuroimage 51: 512–520.
8. Baudrexel S. Witte T. Seifried C. von Wegner F. Beissner F. Klein J. et al. (2011) Resting state fMRI reveals increased subthalamic nucleus-motor cortex connectivity in Parkinson's disease. Neuroimage 55: 1728–1738.
9. Beyer M. Janvin C. Larsen J. Aarsland D. (2007) A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 78: 254–259.
10. Biswal B. Yetkin F. Haughton V. Hyde J. (1995) Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 34: 537–541.
11. Biundo R. Formento-Dojot P. Facchini S. Vallelunga A. Ghezzo L. Foscolo L. et al. (2011) Brain volume changes in Parkinson's disease and their relationship with cognitive and behavioural abnormalities. J Neurol Sci 310: 64–69.
12. Blain C. Barker G. Jarosz J. Coyle N. Landau S. Brown R. et al. (2006) Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI. Neurology 67: 2199–2205.
13. Boelmans K. Holst B. Hackius M. Finsterbusch J. Gerloff C. Fiehler J. et al. (2012) Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy. Mov Disord 27: 421–427.
14. Bonneville F. Welter M. Elie C. du Montcel S. Hasboun D. Menuel C. et al. (2005) Parkinson disease, brain volumes, and subthalamic nucleus stimulation. Neurology 64: 1598–1604.
15. Boxer A. Geschwind M. Belfor N. Gorno-Tempini M. Schauer G. Miller B. et al. (2006) Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 63: 81–86.
16. Brenneis C. Seppi K. Schocke M. Benke T. Wenning G. Poewe W. (2004) Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 75: 246–249.
17. Brenneis C. Seppi K. Schocke M. Muller J. Luginger E. Bosch S. et al. (2003) Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy. Mov Disord 18: 1132–1138.
18. Brooks D. Pavese N. (2010) Imaging non-motor aspects of Parkinson's disease. Prog Brain Res 184: 205–218.
19. Bullmore E. Sporns O. (2009) Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci 10: 186–198.
20. Burton E. McKeith I. Burn D. Williams E. O'Brien J. (2004) Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 127: 791–800.
21. Cardoso E. Maia F. Fregni F. Myczkowski M. Melo L. Sato J. et al. (2009) Depression in Parkinson's disease: convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus. Neuroimage 47: 467–472.
22. Cerasa A. Messina D. Pugliese P. Morelli M. Lanza P. Salsone M. et al. (2011) Increased prefrontal volume in PD with levodopa-induced dyskinesias: a voxel-based morphometry study. Mov Disord 26: 807–812.
23. Chan L. Rumpel H. Yap K. Lee E. Loo H. Ho G. et al. (2007) Case control study of diffusion tensor imaging in Parkinson's disease. J Neurol Neurosurg Psychiatry 78: 1383–1386.
24. Cho Z. Oh S. Kim J. Park S. Kwon D. Jeong H. et al. (2011) Direct visualization of Parkinson's disease by in vivo human brain imaging using 7.0T magnetic resonance imaging. Mov Disord 26: 713–718.
25. Cochrane C. Ebmeier K. (2013) Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis. Neurology 80: 857–864.
26. Cordato N. Duggins A. Halliday G. Morris J. Pantelis C. (2005) Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 128: 1259–1266.
27. Dale A. Fischl B. Sereno M. (1999) Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9: 179–194.
28. Damier P. Hirsch E. Agid Y. Graybiel A. (1999) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122: 1437–1448.
29. Dell'acqua F. Catani M. (2012) Structural human brain networks: hot topics in diffusion tractography. Curr Opin Neurol 25: 375–383.
30. Destrieux C. Fischl B. Dale A. Halgren E. (2010) Automatic parcellation of human cortical gyri and sulci using standard anatomical nomenclature. Neuroimage 53: 1–15.
31. Detre J. Leigh J. Williams D. Koretsky A. (1992) Perfusion imaging. Magn Reson Med 23: 37–45.
32. Detre J. Rao H. Wang D. Chen Y. Wang Z. (2012) Applications of arterial spin labeled MRI in the brain. J Magn Reson Imaging 35: 1026–1037.
33. Dexter D. Wells F. Lees A. Agid F. Agid Y. Jenner P. et al. (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 52: 1830–1836.
34. Dousset V. Grossman R. Ramer K. Schnall M. Young L. Gonzalez-Scarano F. et al. (1992) Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 182: 483–491.
35. Draganski B. Kherif F. Kloppel S. Cook P. Alexander D. Parker G. et al. (2008) Evidence for segregated and integrative connectivity patterns in the human basal ganglia. J Neurosci 28: 7143–7152.
36. Du G. Lewis M. Styner M. Shaffer M. Sen S. Yang Q. et al. (2011) Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease. Mov Disord 26: 1627–1632.
37. Eckert T. Sailer M. Kaufmann J. Schrader C. Peschel T. Bodammer N. et al. (2004) Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage 21: 229–235.
38. Emir U. Tuite P. Oz G. (2012) Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 Tesla proton MRS. PloS ONE 7 (1): e30918.
39. Esposito F. Tessitore A. Giordano A. de Micco R. Paccone A. Conforti R. et al. (2013) Rhythm-specific modulation of the sensorimotor network in drug-naive patients with Parkinson's disease by levodopa. Brain 136: 710–725.
40. Feldmann A. Illes Z. Kosztolanyi P. Illes E. Mike A. Kover F. et al. (2008) Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study. Mov Disord 23: 42–46.
41. Fernandez-Seara M. Mengual E. Vidorreta M. Aznarez-Sanado M. Loayza F. Villagra F. et al. (2012) Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI. Neuroimage 59: 2743–2750.
42. Fischl B. Sereno M. Dale A. (1999) Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 9: 195–207.
43. Friston K. Frith C. Liddle P. Frackowiak R. (1993) Functional connectivity: the principal-component analysis of large (PET) data sets. J Cereb Blood Flow Metab 13: 5–14.
44. Garcia-Lorenzo D. Longo-Dos Santos C. Ewenczyk C. Leu-Semenescu S. Gallea C. Quattrocchi G. et al. (2013) The coeruleus / subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease. Brain 136: 2120–2129.
45. Gardner R. Boxer A. Trujillo A. Mirsky J. Guo C. Gennatas E. et al. (2013) Intrinsic connectivity network disruption in progressive supranuclear palsy. Ann Neurol 73: 603–616.
46. Good C. Ashburner J. Frackowiak R. (2001) Computational neuroanatomy: new perspectives for neuroradiology. Rev Neurol (Paris) 157: 797–806.
47. Graham J. Paley M. Grunewald R. Hoggard N. Griffiths P. (2000) Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 123: 2423–2431.
48. Groger A. Chadzynski G. Godau J. Berg D. Klose U. (2011) Three-dimensional magnetic resonance spectroscopic imaging in the substantia nigra of healthy controls and patients with Parkinson's disease. Eur Radiol 21: 1962–1969.
49. Haacke E. Cheng N. House M. Liu Q. Neelavalli J. Ogg R. et al. (2005) Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 23: 1–25.
50. Hacker C. Perlmutter J. Criswell S. Ances B. Snyder A. (2012) Resting state functional connectivity of the striatum in Parkinson's disease. Brain 135: 3699–3711.
51. Hardy P. Gash D. Yokel R. Andersen A. Ai Y. Zhang Z. (2005) Correlation of R 2 with total iron concentration in the brains of rhesus monkeys. J Magn Reson Imaging 21: 118–127.
52. Hattingen E. Magerkurth J. Pilatus U. Mozer A. Seifried C. Steinmetz H. et al. (2009) Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease. Brain 132: 3285–3297.
53. Helmich R. Derikx L. Bakker M. Scheeringa R. Bloem B. Toni I. (2009) Spatial remapping of cortico-striatal connectivity in Parkinson's disease. Cereb Cortex 20: 1175–1186.
54. Helmich R. Janssen M. Oyen W. Bloem B. Toni I. (2011) Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor. Ann Neurol 69: 269–281.
55. Helms G. Draganski B. Frackowiak R. Ashburner J. Weiskopf N. (2009) Improved segmentation of deep brain grey matter structures using magnetization transfer (MT) parameter maps. Neuroimage 47: 194–198.
56. Hu M. Taylor-Robinson S. Chaudhuri K. Bell J. Labbe C. Cunningham V. et al. (2000) Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study. Brain 123: 340–352.
57. Hutchinson M. Raff U. Lebedev S. (2003) MRI correlates of pathology in Parkinsonism: segmented inversion recovery ratio imaging (SIRRIM). Neuroimage 20: 1899–1902.
58. Ibarretxe-Bilbao N. Junque C. Marti M. Tolosa E. (2011 a) Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease. J Neurol Sci 310: 70–74.
59. Ibarretxe-Bilbao N. Junque C. Marti M. Tolosa E. (2011 b) Cerebral basis of visual hallucinations in Parkinson's disease: structural and functional MRI studies. J Neurol Sci 310: 79–81.
60. Ibarretxe-Bilbao N. Junque C. Segura B. Baggio H. Marti M. Valldeoriola F. et al. (2012) Progression of cortical thinning in early Parkinson's disease. Mov Disord 27: 1746–1753.
61. Ibarretxe-Bilbao N. Ramirez-Ruiz B. Junque C. Marti M. Valldeoriola F. Bargallo N. et al. (2010) Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations. J Neurol Neurosurg Psychiatry 81: 650–657.
62. Ibarretxe-Bilbao N. Tolosa E. Junque C. Marti M. (2009) MRI and cognitive impairment in Parkinson's disease. Mov Disord 24(Suppl. 2): S748–S753.
63. Jensen J. Helpern J. Ramani A. Lu H. Kaczynski K. (2005) Diffusional kurtosis imaging: the quantification of non-Gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med 53: 1432–1440.
64. Josephs K. Whitwell J. Dickson D. Boeve B. Knopman D. Petersen R. et al. (2008) Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging 29: 280–289.
65. Jubault T. Gagnon J. Karama S. Ptito A. Lafontaine A. Evans A. et al. (2011) Patterns of cortical thickness and surface area in early Parkinson's disease. Neuroimage 55: 462–467.
66. Kamagata K. Motoi Y. Hori M. Suzuki M. Nakanishi A. Shimoji K. et al. (2011) Posterior hypoperfusion in Parkinson's disease with and without dementia measured with arterial spin labeling MRI. J Magn Reson Imaging 33: 803–807.
67. Karagulle Kendi A. Lehericy S. Luciana M. Ugurbil K. Tuite P. (2008) Altered diffusion in the frontal lobe in Parkinson disease. AJNR Am J Neuroradiol 29: 501–505.
68. Kato N. Arai K. Hattori T. (2003) Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 210: 57–60.
69. Kostic V. Agosta F. Petrovic I. Galantucci S. Spica V. Jecmenica-Lukic M. et al. (2010) Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology 75: 857–863.
70. Kwak Y. Peltier S. Bohnen N. Muller M. Dayalu P. Seidler R. (2012) L-DOPA changes spontaneous low-frequency BOLD signal oscillations in Parkinson's disease: a resting state fMRI study. Front Syst Neurosci 6: 52.
71. Kwon D. Kim J. Oh S. Jeong H. Park S. Oh E. et al. (2012) Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease. Ann Neurol 71: 267–277.
72. Langkammer C. Krebs N. Goessler W. Scheurer E. Ebner F. Yen K. et al. (2010) Quantitative MR imaging of brain iron: a postmortem validation study. Radiology 257: 455–462.
73. Le Bihan D. (2003) Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 4: 469–480.
74. Lehericy S. Ducros M. van de Moortele P. Francois C. Thivard L. Poupon C. et al. (2004) Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humans. Ann Neurol 55: 522–529.
75. Lehericy S. Hartmann A. Lannuzel A. Galanaud D. Delmaire C. Bienaimee M. et al. (2010) Magnetic resonance imaging lesion pattern in Guadeloupean Parkinsonism is distinct from progressive supranuclear palsy. Brain 133: 2410–2425.
76. Litvan I. Aarsland D. Adler C. Goldman J. Kulisevsky J. Mollenhauer B. et al. (2011) MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord 26: 1814–1824.
77. Long D. Wang J. Xuan M. Gu Q. Xu X. Kong D. et al. (2012) Automatic classification of early Parkinson's disease with multi-modal MR imaging. PloS ONE 7 (11): e47714.
78. Longoni G. Agosta F. Kostic V. Stojkovic T. Pagani E. Stosic-Opincal T. et al. (2011) MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease. Mov Disord 26: 247–255.
79. Lotfipour A. Wharton S. Schwarz S. Gontu V. Schafer A. Peters A. et al. (2012) High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease. J Magn Reson Imaging 35: 48–55.
80. Lyoo C. Ryu Y. Lee M. (2010) Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia. Mov Disord 25: 496–499.
81. Ma Y. Huang C. Dyke J. Pan H. Alsop D. Feigin A. et al. (2010) Parkinson's disease spatial covariance pattern: noninvasive quantification with perfusion MRI. J Cereb Blood Flow Metab 30: 505–509.
82. Makris N. Schlerf J. Hodge S. Haselgrove C. Albaugh M. Seidman L. et al. (2005) MRI-based surface-assisted parcellation of human cerebellar cortex: an anatomically specified method with estimate of reliability. Neuroimage 25: 1146–1160.
83. Martin W. Wieler M. Gee M. (2008) Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 70: 1411–1417.
84. Melzer T. Watts R. MacAskill M. Pearson J. Rueger S. Pitcher T. et al. (2011) Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease. Brain 134: 845–855.
85. Menke R. Jbabdi S. Miller K. Matthews P. Zarei M. (2010) Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease. Neuroimage 52: 1175–1180.
86. Menke R. Scholz J. Miller K. Deoni S. Jbabdi S. Matthews P. et al. (2009) MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T 1 and DTI study. Neuroimage 47: 435–441.
87. Meppelink A. de Jong B. Teune L. van Laar T. (2010) Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations. Mov Disord 26: 142–147.
88. Messina D. Cerasa A. Condino F. Arabia G. Novellino F. Nicoletti G. et al. (2011) Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Parkinsonism Relat Disord 17: 172–176.
89. Michaeli S. Grohn H. Grohn O. Sorce D. Kauppinen R. Springer C. Jr et al. (2005) Exchange-influenced T2rho contrast in human brain images measured with adiabatic radio frequency pulses. Magn Reson Med 53: 823–829.
90. Michaeli S. Oz G. Sorce D. Garwood M. Ugurbil K. Majestic S. et al. (2007) Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts. Mov Disord 22: 334–340.
91. Minati L. Grisoli M. Carella F. de Simone T. Bruzzone M. Savoiardo M. (2007) Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging. AJNR Am J Neuroradiol 28: 309–313.
92. Minnerop M. Specht K. Ruhlmann J. Schimke N. Abele M. Weyer A. et al. (2007) Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy - a comparison between clinical subtypes and correlations with clinical parameters. Neuroimage 36: 1086–1095.
93. Mori S. Crain B. Chacko V. van Zijl P. (1999) Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol 45: 265–269.
94. Nicoletti G. Lodi R. Condino F. Tonon C. Fera F. Malucelli E. et al. (2006) Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain 129: 2679–2687.
95. Nicoletti G. Tonon C. Lodi R. Condino F. Manners D. Malucelli E. et al. (2008) Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease. Mov Disord 23: 2370–2376.
96. Oba H. Yagishita A. Terada H. Barkovich A. Kutomi K. Yamauchi T. et al. (2005) New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 64: 2050–2055.
97. Ohshita T. Oka M. Imon Y. Yamaguchi S. Mimori Y. Nakamura S. (2000) Apparent diffusion coefficient measurements in progressive supranuclear palsy. Neuroradiology 42: 643–647.
98. Oikawa H. Sasaki M. Tamakawa Y. Ehara S. Tohyama K. (2002) The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. AJNR Am J Neuroradiol 23: 1747–1756.
99. Ordidge R. Gorell J. Deniau J. Knight R. Helpern J. (1994) Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Magn Reson Med 32: 335–341.
100. Oz G. Terpstra M. Tkac I. Aia P. Lowary J. Tuite P. et al. (2006) Proton MRS of the unilateral substantia nigra in the human brain at 4 Tesla: detection of high GABA concentrations. Magn Reson Med 55: 296–301.
101. Padovani A. Borroni B. Brambati S. Agosti C. Broli M. Alonso R. et al. (2006) Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 77: 457–463.
102. Patenaude B. Smith S. Kennedy D. Jenkinson M. (2011) A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56: 907–922.
103. Paviour D. Price S. Jahanshahi M. Lees A. Fox N. (2006) Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 129: 1040–1049.
104. Paviour D. Thornton J. Lees A. Jager H. (2007) Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy. Mov Disord 22: 68–74.
105. Peran P. Cherubini A. Assogna F. Piras F. Quattrocchi C. Peppe A. et al. (2010) Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain 133: 3423–3433.
106. Quattrone A. Nicoletti G. Messina D. Fera F. Condino F. Pugliese P. et al. (2008) MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 246: 214–221.
107. Rademacher J. Engelbrecht V. Burgel U. Freund H. Zilles K. (1999) Measuring in vivo myelination of human white matter fiber tracts with magnetization transfer MR. Neuroimage 9: 393–406.
108. Ramnani N. Behrens T. Penny W. Matthews P. (2004) New approaches for exploring anatomical and functional connectivity in the human brain. Biol Psychiatry 56: 613–619.
109. Rango M. Bonifati C. Bresolin N. (2006) Parkinson's disease and brain mitochondrial dysfunction: a functional phosphorus magnetic resonance spectroscopy study. J Cereb Blood Flow Metab 26: 283–290.
110. Redgrave P. Rodriguez M. Smith Y. Rodriguez-Oroz M. Lehericy S. Bergman H. et al. (2010) Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease. Nat Rev Neurosci 11: 760–772.
111. Righini A. Antonini A. de Notaris R. Bianchini E. Meucci N. Sacilotto G. et al. (2004) MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR Am J Neuroradiol 25: 927–932.
112. Rizzo G. Martinelli P. Manners D. Scaglione C. Tonon C. Cortelli P. et al. (2008) Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain 131: 2690–2700.
113. Ross B. Bluml S. (2001) Magnetic resonance spectroscopy of the human brain. Anat Rec 265 (2): 54–84.
114. Sasaki M. Shibata E. Tohyama K. Takahashi J. Otsuka K. Tsuchiya K. et al. (2006) Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport 17: 1215–1218.
115. Schafer A. Forstmann B. Neumann J. Wharton S. Mietke A. Bowtell R. et al. (2012) Direct visualization of the subthalamic nucleus and its iron distribution using high-resolution susceptibility mapping. Hum Brain Mapp 33: 2831–2842.
116. Schocke M. Seppi K. Esterhammer R. Kremser C. Mair K. Czermak B. et al. (2004) Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage 21: 1443–1451.
117. Seppi K. Poewe W. (2010) Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes. Neuroimaging Clin N Am 20: 29–55.
118. Seppi K. Schocke M. (2005) An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism. Curr Opin Neurol 18: 370–375.
119. Seppi K. Schocke M. Esterhammer R. Kremser C. Brenneis C. Mueller J. et al. (2003) Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the Parkinson variant of multiple system atrophy. Neurology 60: 922–927.
120. Sharman M. Valabregue R. Perlbarg V. Marrakchi-Kacem L. Vidailhet M. Benali H. et al. (2012) Parkinson's disease patients show reduced cortical-subcortical sensorimotor connectivity. Mov Disord, in press.
121. Skidmore F. Yang M. Baxter L. von Deneen K. Collingwood J. He G. et al. (2011 a) Apathy, depression, and motor symptoms have distinct and separable resting activity patterns in idiopathic Parkinson disease. Neuroimage, in press.
122. Skidmore F. Yang M. Baxter L. von Deneen K. Collingwood J. He G. et al. (2011 b) Reliability analysis of the resting state can sensitively and specifically identify the presence of Parkinson disease. Neuroimage, in press.
123. Svenningsson P. Westman E. Ballard C. Aarsland D. (2012) Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol 11: 697–707.
124. Tambasco N. Belcastro V. Sarchielli P. Floridi P. Pierguidi L. Menichetti C. et al. (2011) A magnetization transfer study of mild and advanced Parkinson's disease. Eur J Neurol 18: 471–477.
125. Tessitore A. Amboni M. Cirillo G. Corbo D. Picillo M. Russo A. et al. (2012 a) Regional gray matter atrophy in patients with Parkinson disease and freezing of gait. AJNR Am J Neuroradiol, in press.
126. Tessitore A. Esposito F. Vitale C. Santangelo G. Amboni M. Russo A. et al. (2012 b) Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease. Neurology 79: 2226–2232.
127. Tinaz S. Courtney M. Stern C. (2011) Focal cortical and subcortical atrophy in early Parkinson's disease. Mov Disord 26: 436–441.
128. Vaillancourt D. Spraker M. Prodoehl J. Abraham I. Corcos D. Zhou X. et al. (2009) High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 72: 1378–1384.
129. van Waesberghe J. Kamphorst W. de Groot C. van Walderveen M. Castelijns J. Ravid R. et al. (1999) Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46: 747–754.
130. Wang J. Lin W. Lu C. Weng Y. Ng S. Wang C. et al. (2011) Parkinson disease: diagnostic utility of diffusion kurtosis imaging. Radiology 261: 210–217.
131. Wang Y. Butros S. Shuai X. Dai Y. Chen C. Liu M. et al. (2012) Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging. AJNR Am J Neuroradiol 33: 266–273.
132. Wattendorf E. Welge-Lussen A. Fiedler K. Bilecen D. Wolfensberger M. Fuhr P. et al. (2009) Olfactory impairment predicts brain atrophy in Parkinson's disease. J Neurosci 29: 15410–15413.
133. Weintraub D. Dietz N. Duda J. Wolk D. Doshi J. Xie S. et al. (2012) Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. Brain 135: 170–180.
134. Whitwell J. Avula R. Master A. Vemuri P. Senjem M. Jones D. et al. (2011) Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Parkinsonism Relat Disord 17: 599–605.
135. Wolff S. Balaban R. (1989) Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 10: 135–144.
136. Wu T. Long X. Wang L. Hallett M. Zang Y. Li K. et al. (2011) Functional connectivity of cortical motor areas in the resting state in Parkinson's disease. Hum Brain Mapp 32: 1443–1457.
137. Yoshikawa K. Nakata Y. Yamada K. Nakagawa M. (2004) Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry 75: 481–484.
138. Zhan W. Kang G. Glass G. Zhang Y. Shirley C. Millin R. et al. (2012) Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging. Mov Disord 27: 90–97.
139. Zhang H. Schneider T. Wheeler-Kingshott C. Alexander D. (2012) NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage 61: 1000–1016.
140. Zhang J. Zhang Y. Wang J. Cai P. Luo C. Qian Z. et al. (2010) Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study. Brain Res 1330: 124–130.